ARYA Sciences Acquisition Corp III ARYA
Set alert
— — —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 214.12M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -8.21
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 10.29
- 200-d avg
- 12.36
- 1y target
- 24.89
Key statistics
- Market cap
- 214.12M
- Trailing P/E
- 0.00
- Forward P/E
- -8.21
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 10.29
- 200-day average
- 12.36
Analyst view
Consensus: buy
Buy
Price target (mean) 24.89
Next earnings
Consensus EPS estimate -0.21.
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2020 | Chardan Capital | init | — | Buy |
News
- ARYA Sciences Acquisition Corp III Announces Extraordinary General Meeting Teleconference Details
- Stocks That Hit 52-Week Lows On Friday
- SHAREHOLDER ALERT: WeissLaw LLP Investigates Arya Sciences Acquisition Corp. III
- ARYA Stock Price Increases Over 60%: Why It Happened
- Stocks That Hit 52-Week Highs On Monday
- Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III
- U.S. IPO Weekly Recap: Software And SPACs Shine In A 7-IPO Week
- Stocks That Hit 52-Week Highs On Friday
- Stocks That Hit 52-Week Highs On Monday
Your note
Sign in to keep a note on ARYA — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 6.47% | 1,000,000 | 13.78M | Mar 30, 2021 |
| Bain Capital Life Sciences Investors, LLC | 6.47% | 1,000,000 | 13.78M | Mar 30, 2021 |
| RA Capital Management, L.P. | 6.29% | 971,430 | 13.39M | Mar 30, 2021 |
| Federated Hermes, Inc. | 5.18% | 800,000 | 11.02M | Mar 30, 2021 |
| Alyeska Investment Group, L.P. | 4.84% | 746,991 | 10.29M | Mar 30, 2021 |
| Nantahala Capital Management, LLC | 4.57% | 706,770 | 9.74M | Mar 30, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Federated Hermes Kaufmann Small Cap Fund | 5.18% | 800,000 | 9.00M | Jan 30, 2021 |
| Fidelity Select Portfolios - Biotechnology | 2.71% | 418,718 | 5.77M | Mar 30, 2021 |
| BlackRock Health Sciences Trust II | 2.10% | 324,000 | 4.46M | Mar 30, 2021 |
| Blackrock Funds-Health Sciences Opportunity Portfolio | 2.07% | 320,000 | 4.41M | Mar 30, 2021 |
| Franklin Strategic Series-Franklin Biotechnology Discove | 1.38% | 212,500 | 2.39M | Jan 30, 2021 |
| Blackrock Health Sciences Trust | 0.11% | 16,560 | 228.20K | Mar 30, 2021 |